Dr. Alnimri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2315 Stockton Blvd
Sacramento, CA 95817Phone+1 415-690-6812
Education & Training
- Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 2006 - 2008
- Oregon Health & Science University (OHSU Health)Fellowship, Nephrology, 1997 - 1999
- University of Jordan Faculty of MedicineClass of 1987
Certifications & Licensure
- OR State Medical License 1998 - Present
- CA State Medical License 2008 - 2026
- NY State Medical License 2009 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 16 citationsConversion to Low-Dose Tacrolimus or Rapamycin 3 Months After Kidney Transplantation: A Prospective, Protocol Biopsy-Guided StudyO. Pankewycz, Nicolae Leca, R. Kohli, E. Weber-Shrikant, M. Said
Transplantation Proceedings. 2011-03-01 - 16 citationsObesity in renal transplantation: the role of induction therapy on long-term outcomes.S. K. Patel, O. Pankewycz, R. Kohli, M. Said, Muna A Alnimri
Transplantation Proceedings. 2011-03-01 - 23 citationsLow-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.M. R. Laftavi, Muna A Alnimri, E. Weber-Shrikant, R. Kohli, M. Said
Transplantation Proceedings. 2011-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: